-
-
- R&D Unit
- Industrial Vaccine Production Unit
- Vaccine and Immunization Training Unit
- Vaccine Epidemiology Unit
- Preclinical and Clinical Research and Project Coordination Unit
- Epidemiology of Pandemic-Risk Infectious Agents Unit
- Bioterrorism Unit
- Laboratory Animal Production/Testing and Preclinical Research Unit
- Tissue Culture Collection, Viral and Bacterial Culture Banking Unit
- Quality Control Laboratory Unit
- Training, Administrative, and Financial Services Unit
-
-
-
- Announcements
- Key Dates
- FAQ
- Contact
The History of Vaccines and Infectious Diseases during the Ottoman Empire and the Republican Era: Project for the Creation of Source Documentation
The project aims to investigate and publish the history of vaccines and infectious diseases during the Ottoman Empire and the Republican Era, spanning from the 19th century to the late 20th century. This research is based on Ottoman and
A Novel, Rapid, and Simplified Approach for Streptococcus pneumoniae Detection: Project for the Design of a Molecular Imprinting-Based Rapid Test Kit for High-Sensitivity Determination of Pneumolysin in Urine
Streptococcus pneumoniae belongs to the class of bacteria that produce toxins capable of forming pores in host cells. As it secretes pneumolysin to create these pores, the pneumolysin protein is present in the patient's urine during every stage
Recombinant Production and Innovative Purification of Pneumolysin Protein: A Promising Multi-Functional Pneumococcal Virulence Factor for Next-Generation Pneumococcal Vaccines and Alternative Treatments
Streptococcus pneumoniae is an opportunistic pathogen responsible for widespread infectious diseases and remains a significant global public health concern, particularly for children, individuals over the age of 65, and immunocompromised populations.
TURKOVAC
Prof Dr. Aykut Ozdarendeli and his coworkers from Erciyes University confirmed the Covid-19 virus on March 25, 2020
Post-Preclinical Process Development for the Production of Recombinant Vaccine and Inactive Virus Vaccine Against SARS-CoV-2 Virus
The coronavirus disease (COVID-19) has spread all over the world in a short time and has been declared a pandemic.